Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.35 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29451158 | 1.00 | MME (0.35) | MMECTRB1ACESLC15A2 | |
| SCHEMBL30724654 | 0.99 | MME (0.36) | MMECTRB1ACE | |
| SCHEMBL30781078 | 0.99 | MME (0.36) | MMECTRB1ACE | |
| SCHEMBL30781160 | 0.99 | MME (0.36) | MMECTRB1ACE | |
| SCHEMBL30781156 | 0.96 | MME (0.39) | MMECTRB1SLC15A2 | |
| SCHEMBL31113634 | 0.95 | CTRB1 (0.36) | MMECTRB1ACESLC15A2 | |
| SCHEMBL3916119 | 0.93 | CTRB1 (0.37) | MMECTRB1ACE | |
| SCHEMBL749822 | 0.93 | CTRB1 (0.37) | MMECTRB1ACE | |
| SCHEMBL3810013 | 0.93 | CTRB1 (0.37) | MMECTRB1ACE | |
| SCHEMBL17293240 | 0.93 | CTRB1 (0.37) | MMECTRB1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099172-A1 | SPHINGOLIPID BASED HAIR TREATMENT | SEDERMA (FR) | 2026-05-15 | — | — | WO | disclosed |
| US-20230398049-A1 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | SEDERMA (FR) | 2023-12-14 | — | — | US | disclosed |
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | GLO PHARMA INC (US) | 2023-08-31 | — | — | US | disclosed |
| EP-3519061-B1 | TOPICAL SLIMMING COSMETIC TREATMENT | SEDERMA SA (FR) | 2023-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270635-A1 | METHODS AND COMPOSITIONS FOR COSMETIC APPLICATIONS | CUTA, GLA, LIPA | MME 1383/4885CTRB1 788/4885ACE 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.